FDA Inspection 1020395 — Gulf Coast Regional Blood Center at Pearland

Gulf Coast Regional Blood Center at Pearland — FEI 3006341650

The FDA completed an inspection of Gulf Coast Regional Blood Center at Pearland on July 27, 2017 in Pearland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 27, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pearland, TX (United States)